These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27203170)

  • 1. [Vascular calcifications, the hidden side effects of vitamin K antagonists].
    Bennis Y; Vengadessane S; Bodeau S; Gras V; Bricca G; Kamel S; Liabeuf S
    Therapie; 2016 Sep; 71(4):355-63. PubMed ID: 27203170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular calcification: the price to pay for anticoagulation therapy with vitamin K-antagonists.
    Chatrou ML; Winckers K; Hackeng TM; Reutelingsperger CP; Schurgers LJ
    Blood Rev; 2012 Jul; 26(4):155-66. PubMed ID: 22520397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding, vertebral fractures and vascular calcifications in patients treated with warfarin: hope for lower risks with alternative therapies.
    Fusaro M; Crepaldi G; Maggi S; D'Angelo A; Calo L; Miozzo D; Fornasieri A; Gallieni M
    Curr Vasc Pharmacol; 2011 Nov; 9(6):763-9. PubMed ID: 21623708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin and Vascular Calcification.
    Poterucha TJ; Goldhaber SZ
    Am J Med; 2016 Jun; 129(6):635.e1-4. PubMed ID: 26714212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of vasculopathy by vitamin K supplementation: can we turn fiction into fact?
    Brandenburg VM; Schurgers LJ; Kaesler N; Püsche K; van Gorp RH; Leftheriotis G; Reinartz S; Koos R; Krüger T
    Atherosclerosis; 2015 May; 240(1):10-6. PubMed ID: 25744701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of vitamin K in vascular calcification of patients with chronic kidney disease.
    Wuyts J; Dhondt A
    Acta Clin Belg; 2016 Dec; 71(6):462-467. PubMed ID: 27254816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin K antagonism aggravates chronic kidney disease-induced neointimal hyperplasia and calcification in arterialized veins: role of vitamin K treatment?
    Zaragatski E; Grommes J; Schurgers LJ; Langer S; Kennes L; Tamm M; Koeppel TA; Kranz J; Hackhofer T; Arakelyan K; Jacobs MJ; Kokozidou M
    Kidney Int; 2016 Mar; 89(3):601-11. PubMed ID: 26466318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research progress of warfarin-associated vascular calcification and its possible therapy.
    Zhang YT; Tang ZY
    J Cardiovasc Pharmacol; 2014 Jan; 63(1):76-82. PubMed ID: 24072176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warfarin induces cardiovascular damage in mice.
    Krüger T; Oelenberg S; Kaesler N; Schurgers LJ; van de Sandt AM; Boor P; Schlieper G; Brandenburg VM; Fekete BC; Veulemans V; Ketteler M; Vermeer C; Jahnen-Dechent W; Floege J; Westenfeld R
    Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2618-24. PubMed ID: 23990204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of circulating Matrix Gla-Protein and anticoagulation status in patients with aortic valve calcification.
    Koos R; Krueger T; Westenfeld R; Kühl HP; Brandenburg V; Mahnken AH; Stanzel S; Vermeer C; Cranenburg EC; Floege J; Kelm M; Schurgers LJ
    Thromb Haemost; 2009 Apr; 101(4):706-13. PubMed ID: 19350115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype.
    Schurgers LJ; Joosen IA; Laufer EM; Chatrou ML; Herfs M; Winkens MH; Westenfeld R; Veulemans V; Krueger T; Shanahan CM; Jahnen-Dechent W; Biessen E; Narula J; Vermeer C; Hofstra L; Reutelingsperger CP
    PLoS One; 2012; 7(8):e43229. PubMed ID: 22952653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin K: key vitamin in controlling vascular calcification in chronic kidney disease.
    Schurgers LJ
    Kidney Int; 2013 May; 83(5):782-4. PubMed ID: 23633049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vitamin K antagonists: from discovery to pharmacogenetics].
    Moreau C; Loriot MA; Siguret V
    Ann Biol Clin (Paris); 2012 Oct; 70(5):539-51. PubMed ID: 23047901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fever as a risk factor for increased response to vitamin K antagonists: a review of the evidence and potential mechanisms.
    Self TH; Oliphant CS; Reaves AB; Richardson AM; Sands CW
    Thromb Res; 2015 Jan; 135(1):5-8. PubMed ID: 25456000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Is the use of vitamin K antagonists harmful in patients with CDK?].
    Pham TT; Saudan P
    Rev Med Suisse; 2012 Feb; 8(330):462-5. PubMed ID: 22452132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The realm of vitamin K dependent proteins: shifting from coagulation toward calcification.
    Willems BA; Vermeer C; Reutelingsperger CP; Schurgers LJ
    Mol Nutr Food Res; 2014 Aug; 58(8):1620-35. PubMed ID: 24668744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs).
    van Gorp RH; Schurgers LJ
    Nutrients; 2015 Nov; 7(11):9538-57. PubMed ID: 26593943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The matrix-gla protein awakening may lead to the demise of vascular calcification].
    Delanaye P; Liabeuf S; Bouquegneau A; Cavalier É; Massy ZA
    Nephrol Ther; 2015 Jul; 11(4):191-200. PubMed ID: 25794931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracranial calcifications under vitamin K antagonists or direct oral anticoagulants: Results from the French VIKING study in older adults.
    Annweiler G; Labriffe M; Ménager P; Ferland G; Brangier A; Annweiler C;
    Maturitas; 2020 Feb; 132():35-39. PubMed ID: 31883661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vascular calcifications and vitamin K deficiency: a modifiable risk factor in chronic kidney disease].
    Phan O; Burnier M
    Rev Med Suisse; 2013 Feb; 9(375):451-2, 454-5. PubMed ID: 23539811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.